RESEARCH TRIANGLE PARK, NC--(Marketwired - December 20, 2016) - A new study of two dozen companies found that half of surveyed pharmaceutical firms continue to rely heavily on patient adherence vendors' experience level and reputation when outsourcing any part of their initiatives. Furthermore, 50% of healthcare companies also took into account how well vendors demonstrated an understanding of their specific patient types when selecting outsourced partners.
But other aspects of patient adherence vendors' strategic approaches have crept into the pharmaceutical industry's due diligence when selecting an outsourced partner. According to the study, Patient Adherence Program Planning: Drive Compliance to Improve Treatment Outcomes, 38% of surveyed pharma firms find the following three qualifications the most important when selecting suitable patient adherence vendors:
- Therapeutic area of knowledge
- Initiative strategy
The study also found that 25% of surveyed healthcare firms reported that they examine vendors' complete solutions. However, the aspects of patient compliance, cost efficiency, measurable outcomes, and technology were only used to select vendors by 13% of surveyed firms.
"For many companies, outsourcing is a key resource for developing and implementing patient adherence initiatives," said Adam Bianchi, senior director of research at Cutting Edge Information. "Not all firms have the full resources necessary to create and launch these objectives in-house, especially since teams have a wide range of channels to reach consumers."
Experienced patient adherence vendors can either create unique strategies or develop and design innovative patient-focused solutions. However, some drug companies may maintain patient focused strategies, but not possess the resources to manage ongoing projects or application upkeep. Therefore, these pharmaceutical companies would select vendors from a preferred list based on their capabilities and cost-effectiveness.
Patient Adherence Program Planning: Drive Compliance to Improve Treatment Outcomes, available at https://www.cuttingedgeinfo.com/product/patient-adherence-program-planning/, examines how pharmaceutical, biotechnology and other life science companies develop and support patient adherence topics. The report includes detailed benchmarking metrics and case studies of winning initiatives, including budgets, timing, outsourcing and vendor selection, as well as program channels – including digital and mobile resources – for new patient adherence initiatives.
The report is a decision support tool for life science companies seeking to implement or improve their approaches to patient adherence. The report is designed to help executives:
- Develop a winning combination of patient adherence activities across a range of media.
- Take advantage of new patient adherence technologies and strategies, such as gamification.
- Benchmark budget and staffing resources for patient adherence initiatives.
- Discover industry trends and insights into new approaches for patient adherence programs.
For more information about Cutting Edge Information's patient adherence research and to obtain a copy of Patient Adherence Program Planning: Drive Compliance to Improve Treatment Outcomes, visit https://www.cuttingedgeinfo.com.
Image Available: http://www.marketwire.com/library/MwGo/2016/12/19/11G125561/Images/December_20_2016_-_PH226_-_HH_-_Pharma_Companies_D-8759fa40645fb1e3b0763c72fdc4f207.jpg